Immunotherapy for Glioma. Promises and Challenges

Seunggu (Jude) Han, Corinna Zygourakis, Michael Lim, Andrew T. Parsa

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Novel immunotherapeutic modalities are being pursed in the treatment of high-grade gliomas. This article explains how tumors suppress immune function in the brain. It specifically describes the ways in which tumors limit effective communication with immune cells, secrete immune-inhibitory cytokines and molecules, and express molecules that induce apoptosis of immune cells. It also defines 3 different immunotherapeutic approaches to counteract this tumor-associated immunosuppression: cytokine therapy, passive immunotherapy (either serotherapy or adoptive immunotherapy), and active immunotherapy. Although immunotherapeutic approaches have met with mixed success so far, immunotherapy continues to be actively pursued because of its potential to attack infiltrating high-grade gliomas.

Original languageEnglish (US)
Pages (from-to)357-370
Number of pages14
JournalNeurosurgery Clinics of North America
Volume23
Issue number3
DOIs
StatePublished - Jul 1 2012
Externally publishedYes

Fingerprint

Glioma
Immunotherapy
Passive Immunization
Cytokines
Adoptive Immunotherapy
Active Immunotherapy
Neoplasms
Immunosuppression
Apoptosis
Brain
Therapeutics

Keywords

  • B cells
  • Brain tumors
  • Central nervous system
  • Cytokines
  • Glioblastoma multiforme
  • Glioma
  • Immunotherapy
  • T cells

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Immunotherapy for Glioma. Promises and Challenges. / Han, Seunggu (Jude); Zygourakis, Corinna; Lim, Michael; Parsa, Andrew T.

In: Neurosurgery Clinics of North America, Vol. 23, No. 3, 01.07.2012, p. 357-370.

Research output: Contribution to journalReview article

Han, Seunggu (Jude) ; Zygourakis, Corinna ; Lim, Michael ; Parsa, Andrew T. / Immunotherapy for Glioma. Promises and Challenges. In: Neurosurgery Clinics of North America. 2012 ; Vol. 23, No. 3. pp. 357-370.
@article{27e986aaad6d4626a1cc9dcf91556be7,
title = "Immunotherapy for Glioma. Promises and Challenges",
abstract = "Novel immunotherapeutic modalities are being pursed in the treatment of high-grade gliomas. This article explains how tumors suppress immune function in the brain. It specifically describes the ways in which tumors limit effective communication with immune cells, secrete immune-inhibitory cytokines and molecules, and express molecules that induce apoptosis of immune cells. It also defines 3 different immunotherapeutic approaches to counteract this tumor-associated immunosuppression: cytokine therapy, passive immunotherapy (either serotherapy or adoptive immunotherapy), and active immunotherapy. Although immunotherapeutic approaches have met with mixed success so far, immunotherapy continues to be actively pursued because of its potential to attack infiltrating high-grade gliomas.",
keywords = "B cells, Brain tumors, Central nervous system, Cytokines, Glioblastoma multiforme, Glioma, Immunotherapy, T cells",
author = "Han, {Seunggu (Jude)} and Corinna Zygourakis and Michael Lim and Parsa, {Andrew T.}",
year = "2012",
month = "7",
day = "1",
doi = "10.1016/j.nec.2012.05.001",
language = "English (US)",
volume = "23",
pages = "357--370",
journal = "Neurosurgery Clinics of North America",
issn = "1042-3680",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Immunotherapy for Glioma. Promises and Challenges

AU - Han, Seunggu (Jude)

AU - Zygourakis, Corinna

AU - Lim, Michael

AU - Parsa, Andrew T.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Novel immunotherapeutic modalities are being pursed in the treatment of high-grade gliomas. This article explains how tumors suppress immune function in the brain. It specifically describes the ways in which tumors limit effective communication with immune cells, secrete immune-inhibitory cytokines and molecules, and express molecules that induce apoptosis of immune cells. It also defines 3 different immunotherapeutic approaches to counteract this tumor-associated immunosuppression: cytokine therapy, passive immunotherapy (either serotherapy or adoptive immunotherapy), and active immunotherapy. Although immunotherapeutic approaches have met with mixed success so far, immunotherapy continues to be actively pursued because of its potential to attack infiltrating high-grade gliomas.

AB - Novel immunotherapeutic modalities are being pursed in the treatment of high-grade gliomas. This article explains how tumors suppress immune function in the brain. It specifically describes the ways in which tumors limit effective communication with immune cells, secrete immune-inhibitory cytokines and molecules, and express molecules that induce apoptosis of immune cells. It also defines 3 different immunotherapeutic approaches to counteract this tumor-associated immunosuppression: cytokine therapy, passive immunotherapy (either serotherapy or adoptive immunotherapy), and active immunotherapy. Although immunotherapeutic approaches have met with mixed success so far, immunotherapy continues to be actively pursued because of its potential to attack infiltrating high-grade gliomas.

KW - B cells

KW - Brain tumors

KW - Central nervous system

KW - Cytokines

KW - Glioblastoma multiforme

KW - Glioma

KW - Immunotherapy

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=84863006570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863006570&partnerID=8YFLogxK

U2 - 10.1016/j.nec.2012.05.001

DO - 10.1016/j.nec.2012.05.001

M3 - Review article

C2 - 22748649

AN - SCOPUS:84863006570

VL - 23

SP - 357

EP - 370

JO - Neurosurgery Clinics of North America

JF - Neurosurgery Clinics of North America

SN - 1042-3680

IS - 3

ER -